Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol HandiHaler vs Serevent Diskus in COPD
NCT02242227Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Sep 2005; status: completed.
02
Drugs
salmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02242227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242227.